288 related articles for article (PubMed ID: 12037146)
1. Chronic hepatitis B.
Lok AS
N Engl J Med; 2002 May; 346(22):1682-3. PubMed ID: 12037146
[No Abstract] [Full Text] [Related]
2. [Lamivudine treatment for hepatitis B].
Lamivudine Clincal Practice Group
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
[No Abstract] [Full Text] [Related]
3. [Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].
Tang Y; Chen G; Zheng R
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):89. PubMed ID: 11983118
[No Abstract] [Full Text] [Related]
4. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of lamiduvine-resistant mutant chronic hepatitis B with interferon alpha].
Pariente A; Tachet A; Poveda JD
Gastroenterol Clin Biol; 2002 Nov; 26(11):1059-60. PubMed ID: 12483147
[No Abstract] [Full Text] [Related]
6. [Some strategies for the long-term treatment of chronic hepatitis B].
Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):537-8. PubMed ID: 16042895
[No Abstract] [Full Text] [Related]
7. Lamivudine treatment for children with interferon refractory chronic hepatitis B.
Koçak N; Saltik IN; Ozen H; Yüce ; Gürakan F
Hepatology; 2000 Feb; 31(2):545. PubMed ID: 10691379
[No Abstract] [Full Text] [Related]
8. [Detection and clinical significance of serum HBeAg and HBeAg/IC during the treatment of chronic hepatitis B patients with lamivudine].
Zhang H; Zhang SL; Ye F; Yang Q
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):364-5. PubMed ID: 12837219
[No Abstract] [Full Text] [Related]
9. Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
Cooksley G
Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):12-3. PubMed ID: 16265091
[No Abstract] [Full Text] [Related]
10. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?
Terrault NA
Hepatology; 2000 Sep; 32(3):675-7. PubMed ID: 10991635
[No Abstract] [Full Text] [Related]
11. Treatment of HBe antigen-positive chronic hepatitis B.
Heathcote J
Semin Liver Dis; 2003 Feb; 23(1):69-80. PubMed ID: 12616452
[TBL] [Abstract][Full Text] [Related]
12. [Antiviral treatment of HBeAg positive chronic hepatitis B].
Wang GQ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):540. PubMed ID: 16042897
[No Abstract] [Full Text] [Related]
13. [Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy].
Lu WL; Xie DY; Yao JL; Yao GB; Cui ZY; Zhang DF; Wu L
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):429-31. PubMed ID: 15268810
[TBL] [Abstract][Full Text] [Related]
14. Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
Akarca US; Ersoz G; Gunsar F; Karasu Z; Saritas E; Yuce G; Batur Y
Antivir Ther; 2004 Jun; 9(3):325-34. PubMed ID: 15259895
[TBL] [Abstract][Full Text] [Related]
15. Peginterferon and lamivudine for hepatitis B.
Assy NN; Hussein O
N Engl J Med; 2004 Dec; 351(27):2879; author reply 2879. PubMed ID: 15625344
[No Abstract] [Full Text] [Related]
16. [Therapeutic effect of lamivudine on liver fibrosis resulted from chronic hepatitis B].
Tan XY; Hu SY
Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):753. PubMed ID: 14697142
[No Abstract] [Full Text] [Related]
17. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
[TBL] [Abstract][Full Text] [Related]
18. Sustained response after lamivudine treatment in HBe minus chronic hepatitis B.
Madonia S; Tinè F; Malizia G; Giannuoli G; Concetta Cascioni M; Di Stefano R
J Hepatol; 2004 May; 40(5):870-1. PubMed ID: 15094240
[No Abstract] [Full Text] [Related]
19. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
Marrone A; Zampino R; D'Onofrio M; Ricciotti R; Ruggiero G; Utili R
J Hepatol; 2004 Dec; 41(6):1064-5. PubMed ID: 15582146
[No Abstract] [Full Text] [Related]
20. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine.
Gauthier J; Bourne EJ; Lutz MW; Crowther LM; Dienstag JL; Brown NA; Condreay LD
J Infect Dis; 1999 Dec; 180(6):1757-62. PubMed ID: 10558928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
